Egypt’s drug authority discusses market stability with global pharma firms
The head of the Egyptian Drug Authority (EDA) has met with representatives of multinational pharmaceutical companies to discuss mechanisms for strengthening the country’s drug system and supporting investment. EDA Chairman Dr. Ali El-Ghamrawy affirmed the authority’s keenness to enhance its
Minapharm, Bayer sign strategic agreement to localize pharmaceutical manufacturing in Egypt
Chairperson of the Egyptian Drug Authority (EDA), Ali Ghamrawy, witnessed the signing of a cooperation agreement between Minapharm Pharmaceuticals and Bayer International. The ceremony was held in the New Administrative Capital under the patronage—and in the presence—of Khaled Abdel Ghaffar,
Egyptian Drug Authority, Sandoz discuss oncology drug localisation
The Chairperson of the Egyptian Drug Authority (EDA), Ali Ghamrawy, has met with a high-level delegation from Sandoz, a global pharmaceutical company, to discuss strengthening cooperation and localising the production of oncology drugs in Egypt. The Sandoz delegation was headed
Egypt’s pharmaceutical market records EGP 277bn annual sales: EDA
Ali Ghamrawy, Chairperson of the Egyptian Drug Authority (EDA) has reported that the total sales of Egypt’s pharmaceutical market from October 2023 to September 2024 reached 3.6 billion units, valued at approximately EGP 277bn, positioning it as one of the